Photo by atikahakhtar from unsplash
Eosinophilic fasciitis (EF) is a rare condition in children that is typically treated with systemic corticosteroids. We present the case of a 9‐year‐old boy with biopsy‐proven EF, refractory to systemic… Click to show full abstract
Eosinophilic fasciitis (EF) is a rare condition in children that is typically treated with systemic corticosteroids. We present the case of a 9‐year‐old boy with biopsy‐proven EF, refractory to systemic corticosteroids and methotrexate. The tyrosine kinase inhibitor imatinib was added as adjuvant therapy, leading to improvement in joint function and skin laxity. Our case is the first to suggest the anti‐fibrotic properties of imatinib may benefit EF patients.
Keywords:
fasciitis;
imatinib potentially;
eosinophilic fasciitis;
potentially effective;
effective therapeutic;
therapeutic alternative
Journal Title: Pediatric Dermatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatric Dermatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!